Structural Thermodynamics of Human Apolipoprotein C-1

人载脂蛋白 C-1 的结构热力学

• 批准号: 6691730
• 负责人: Olga Gursky
• 金额: $ 28.75万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-15 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6691730
• 关键词: Structural; Thermodynamics; Human; Apolipoprotein

DESCRIPTION (provided by applicant): The long-term objective of this project is to determine in molecular detail the energetic-structure-function relationship in exchangeable apolipoproteins and lipoproteins, thereby providing an insight into molecular mechanisms of lipoprotein action in the pathogenesis of atherosclerosis and other lipoprotein-related diseases. Exchangeable apolipoproteins are soluble protein components of lipoproteins that mediate lipid and cholesterol transport and metabolism and play crucial roles in the pathogenesis of atherosclerosis, coronary heart disease, stroke and other major human disorders. Structural stability and compositional variability of lipoproteins are essential for their functions, and have to be understood in detail in order to elucidate molecular mechanisms of lipoprotein action in normal and in diseased states. The proposed work addresses this long-term goal through detailed studies of the energetics, structure and lipid binding function of two small human plasma apolipoproteins, apoC-1 and apoA-2. ApoC-1 delays the clearance of potentially atherogenic triglyceride-rich particles by inhibiting their uptake via the apoE-mediated low-density lipoprotein receptor-related pathway. The ability of apoC-1 to activate lecithin:cholesterol acyltransferase (LCAT) may account for normal plasma levels of cholesterol esters in subjects with deficiency of the major LCAT activator, apoA-1. ApoA-2 ability to displace apoA-1 from high-density lipoproteins (HDL) affects the antiatherogenic functions of HDL. Energetic and structural analyses of lipid-free and lipid-bound human apoA-2, apoC-1 and a series of apoC-1 mutants targeted towards key structural regions will be carried out by using a combination of far- and near-UV circular dichroism and fluorescence spectroscopy, electron microscopy, differential scanning calorimetry, and x-ray diffraction methods. Such analysis will determine, at the level of individual amino acids, the roles of key structural elements in apoC-1 for its folding, stability and lipid binding properties; identify critical determinants for the Lp stability and their relation to the kinetics of apolipoprotein transfer among lipoproteins in the course of lipoprotein metabolism; crystallize apoC-1 and analyze its crystal structure that may provide a model for a functional apolipoprotein conformation. The results will provide the energetic and structural basis for understanding molecular mechanisms of lipoprotein action in normal and diseased states.

描述（由申请人提供）：该项目的长期目标是在分子细节上确定可交换载脂蛋白和脂蛋白的能量-结构-功能关系，从而深入了解脂蛋白在动脉粥样硬化和其他脂蛋白相关疾病的发病机制中的分子机制。可交换载脂蛋白是脂蛋白的可溶性蛋白质成分，介导脂质和胆固醇的转运和代谢，在动脉粥样硬化、冠心病、中风和其他主要人类疾病的发病机制中发挥着至关重要的作用。脂蛋白的结构稳定性和组成变异性对其功能至关重要，必须详细了解脂蛋白的结构稳定性和组成变异性，以阐明脂蛋白在正常和患病状态下作用的分子机制。拟议的工作通过对两种小型人血浆载脂蛋白 apoC-1 和 apoA-2 的能量学、结构和脂质结合功能的详细研究来解决这一长期目标。 ApoC-1 通过 apoE 介导的低密度脂蛋白受体相关途径抑制富含甘油三酯颗粒的摄取，从而延迟潜在致动脉粥样硬化的富含甘油三酯颗粒的清除。 apoC-1 激活卵磷脂：胆固醇酰基转移酶 (LCAT) 的能力可能是缺乏主要 LCAT 激活剂 apoA-1 的受试者中胆固醇酯血浆水平正常的原因。 ApoA-2 从高密度脂蛋白 (HDL) 中取代 apoA-1 的能力会影响 HDL 的抗动脉粥样硬化功能。将结合远、近紫外圆二色性和荧光光谱、电子显微镜、差示扫描量热法和 X 射线衍射方法，对无脂和脂结合的人 apoA-2、apoC-1 和一系列针对关键结构区域的 apoC-1 突变体进行能量和结构分析。此类分析将在单个氨基酸水平上确定 apoC-1 中关键结构元件在其折叠、稳定性和脂质结合特性方面的作用；确定 Lp 稳定性的关键决定因素及其与脂蛋白代谢过程中脂蛋白之间载脂蛋白转移动力学的关系；结晶 apoC-1 并分析其晶体结构，这可能为功能性载脂蛋白构象提供模型。这些结果将为理解正常和疾病状态下脂蛋白作用的分子机制提供能量和结构基础。